Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-037022
Filing Date
2016-08-10
Accepted
2016-08-10 16:24:29
Documents
82
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xtnt20160720_10q.htm 10-Q 698035
2 EXHIBIT 10.3 ex10-3.htm EX-10.3 40252
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 10198
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 10250
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 5270
6 EXHIBIT 32.2 ex32-2.htm EX-32.2 5854
  Complete submission text file 0001437749-16-037022.txt   5059766

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT xtnt-20160630.xml EX-101.INS 886939
8 XBRL TAXONOMY EXTENSION SCHEMA xtnt-20160630.xsd EX-101.SCH 68624
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xtnt-20160630_cal.xml EX-101.CAL 50440
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xtnt-20160630_def.xml EX-101.DEF 451019
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE xtnt-20160630_lab.xml EX-101.LAB 393674
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xtnt-20160630_pre.xml EX-101.PRE 477691
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 161821820
SIC: 2836 Biological Products, (No Diagnostic Substances)